Analysis of the Human Carcinoembryonic Antigen Promoter Core Region in Colorectal Carcinoma-Selective Cytosine Deaminase Gene Therapy

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700082
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CEA-negative Glioblastoma and Melanoma Cells Are Sensitive to Cytosine Deaminase/5-Fluorocytosine Therapy Directed by the Carcinoembryonic Antigen Promoter.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2004English

Oncolytic Adenoviral Vector Carrying the Cytosine Deaminase Gene for Melanoma Gene Therapy

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2006English

Influence of the DCC Gene on Proliferation and Carcinoembryonic Antigen Expression in the Human Colorectal Cancer Cell Line SW1116

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Cytosine Deaminase as a Negative Selective Marker for Arabidopsis

Plant Molecular Biology
MedicineGeneticsAgronomyPlant ScienceCrop Science
1994English

Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma

Asian Pacific Journal of Cancer Prevention
2019English

Functional Analysis of a Remarkable Eukaryotic Promoter, the Human Adenosine Deaminase Promoter: 14

Pediatric Research
Child HealthPediatricsPerinatology
1985English

Carcinoembryonic Antigen in the Urine of Patients With Urothelial Carcinoma

BMJ
1972English

In Vivo Gene Therapy for Colon Cancer Using Adenovirus-Mediated, Transfer of the Fusion Gene Cytosine Deaminase and Uracil Phosphoribosyltransferase

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2001English

Association of Medullary Carcinoma of the Thyroid With Carcinoembryonic Antigen

British Journal of Cancer
Cancer ResearchOncology
1976English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy